Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Recruiting 2Completed 2Unknown 1Terminated 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

CNS 191Sarcoma 22Gastrointestinal 3Endocrine 3Thoracic 2Lymphoid 2Gynecologic 2Genitourinary 2Dermatologic 2Plasma cell 1Other solid neoplasm 1Other hematologic neoplasm 1NET 1Head & Neck 1Breast 1

Conditions

Neuroendocrine Tumors 70Carcinoma, Neuroendocrine 7Gastro-enteropancreatic neuroendocrine tumor 6Carcinoid Tumor 6Neoplasm Metastasis 5Paraganglioma 3Pancreatic Neoplasms 3Carcinoma, Hepatocellular 3Adenoma, Islet Cell 3Thyroid Neoplasms 2Stomach Neoplasms 2Sarcoma 2Neoplasms 2Lung Neoplasms 2Turcot syndrome 1Triple Negative Breast Neoplasms 1Tertiary Lymphoid Structures 1Teratoma 1Small Intestinal Neuroendocrine Tumor 1Small Cell Lung Carcinoma 1Rectal Neuroendocrine Tumor 1Prostatic Neoplasms 1Pheochromocytoma 1Parkinson Disease 1Pancreatic Neuroendocrine Tumors in MEN1 1Osteomalacia 1Neuroendocrine Tumors With Metastasis 1Neuroendocrine Tumors Metastatic to the Liver 1Neuroendocrine Tumor Grade 3 1Neuroblastoma 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Unknown × Glioblastoma × NET × Clear all
NCT03734913 2020-07-22

A Phase 1 Study of ZSP1602 in Participants With Advanced Solid Tumors

Guangdong Zhongsheng Pharmaceutical Co., Ltd.

Phase 1 Unknown
65 enrolled
CNSDermatologicEndocrineNETThoracic

Carcinoma, Basal Cell, Glioblastoma, Medulloblastoma, Neuroendocrine Tumors, Small Cell Lung Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡